Page 26 - SaxoCell Annual Report22/23
P. 26
Schematic representation of AlloCARTreg vision. A) Closed system automated polyclonal Treg manufacture in the GMP
clean room. B) RevCAR adapter CAR concept for antigen-specific targeting developed by A. Feldmann. C) Schematic of the
AlloCARTreg vision – advanced universal Treg manufacture for organ-targeted off-the-shelf Treg treatment by co-infusion
of indication-specific targeting modules.
21
